Miracle Cancer Drugs Are Making Big Pharma Billions. Others Are Getting Left Behind

(Bloomberg) -- It looked like a massive bust. In one painstaking test after another, AstraZeneca Plc’s combination cancer therapy failed. One of the final-stage trials tanked the U.K. drugmaker’s s...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.